Navigation Links
Tengion Reports Fourth Quarter and Full Year 2011 Financial Results
Date:3/26/2012

to develop and commercialize its product candidates, including the Neo-Kidney Augment and the Neo-Urinary Conduit; and (ii) expectations regarding ongoing and planned preclinical studies and clinical trials.  Although Tengion believes that these statements are based upon reasonable assumptions within the bounds of its knowledge of its business and operations, there are a number of factors that may cause actual results to differ from these statements. For instance there can be no assurance that: (i) the Company will be able to successfully enroll patients in its clinical trials, including its Phase I clinical trial for the Neo-Urinary Conduit; (ii) patients enrolled in the Company's clinical trials will not experience adverse events related to the Company's product candidates, which could delay clinical trials or cause the Company to terminate the development of a product candidate; (iii) the results of the clinical trial for the Neo-Urinary Conduit will support further development of that product candidate; (iv) data from the Company's ongoing preclinical studies will continue to be supportive of advancing its preclinical product candidates; and (v) the Company will be able to progress its product candidates that are undergoing preclinical testing, including the Neo-Kidney Augment, into clinical trials; (vi) the Company will be able enter into strategic partnerships on favorable terms, if at all, or obtain the capital it needs to develop its product candidates and continue its operations and (vii) the Company will be able to reduce the net rental obligation for its Pennsylvania facility prior to the expiration of the existing lease.  For additional factors which could cause actual results to differ from expectations, reference is made to the reports filed by the Company with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended.  The forward looking statements in this release are made only as of the date hereof
'/>"/>
SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
2. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
3. Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM)
4. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
5. Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
6. Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy
7. Tengion Announces First Implantation of Neo-Urinary Conduit™ in Initial Clinical Trial in Patients with Bladder Cancer
8. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
9. Tengion Provides Business Update and Reports Third Quarter 2010 Financial Results
10. Tengion Advances Clinical Trial for Neo-Urinary Conduit™ in Bladder Cancer Patients
11. Tengion Presents New Data in Nine Posters and Two Oral Presentations at TERMIS North America Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... TARRYTOWN, N.Y. , June 29, 2015 /PRNewswire/ ... today announced that the Proceedings of the ... a paper demonstrating that the Company,s proprietary VelociGene ... the rapid identification and preclinical validation of potential ... and treatment of Middle East Respiratory Syndrome (MERS). ...
(Date:6/29/2015)... June 29, 2015 The global insulin ... according to a new study by Grand View Research, Inc. Growing ... presence of high unmet needs in emerging markets such as ... expected to be two of the most significant growth drivers of ... as obesity and growing global geriatric population base are expected to ...
(Date:6/29/2015)... , June 29, 2015  VisionCare Ophthalmic ... visual prosthetic devices for the treatment of ... publication of "Long-Term (60-month) Results for the ... Stratified by Age in Patients with End-Stage ... . The 5-year data show substantial retention ...
Breaking Medicine Technology:Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 2Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 3Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 2Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 3Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 5
... Pharmaceutical companies are dramatically increasing their investments ... demands of a patient-empowered, data-driven, outcomes-focused future in ... company investment in smart phone apps, educational websites, ... increased 78%, as companies embrace a role that ...
... Inc. (Nasdaq: MLAB ) today announced that ... cash dividend of 12 cents per share of common ... record at the close of business on February 25, ... markets electronic instruments and disposables for industrial, pharmaceutical and ...
Cached Medicine Technology:Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 2Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 3Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 4Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 5
(Date:6/29/2015)... ... June 29, 2015 , ... Assurex Health, a ... certain neuropsychiatric and chronic pain conditions, has announced appointments to three key leadership ... Peter Donato, Senior Vice President, Chief Financial Officer; Craig S. Lewis, Senior Vice ...
(Date:6/29/2015)... Fernando Valley, CA (PRWEB) , ... June 29, 2015 , ... ... non-invasive treatments designed to lift and tighten sagging skin. Ulthera is a special treatment ... surgery. Instead, it uses ultrasound technology to gently stimulate collagen production. Ulthera is highly ...
(Date:6/29/2015)... ... , ... The world’s fastest and highest flying production aircraft, the SR-71 Blackbird, ... Virginia. This iconic, supersonic stealth plane will become the focal point of the Museum’s ... ceiling of a historic train station is perhaps one of the most unconventional presentations ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... (Cognizin®) from Kyowa Hakko Bio to French consumers. , The specialized eye health ... oxidative stress caused by free radicals. In addition to Citicoline (Cognizin®), Biomacula provides ...
(Date:6/29/2015)... ... June 29, 2015 , ... Celebrities have many skincare secrets, and ... skin all summer long and beyond. People don’t have to be famous to ... aging process, maintain an even skin tone, avoid breakouts, and take skin health and ...
Breaking Medicine News(10 mins):Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 2Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 3Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:SR-71 Prepares for Flight to Science Museum of Virginia 2Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 2Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 3Health News:Skin Guru Shares Celebrity FACE Secrets For Summer-Proofing The Skin 2Health News:Skin Guru Shares Celebrity FACE Secrets For Summer-Proofing The Skin 3
... half of people in 30s, 40s use them when with ... Six out of every 10 middle-aged Britons do not ... study shows. , Those numbers might be similar for Americans, ... and, given prevailing policies with regard to contraception, may ...
... More than 350 brain tumor patients,caregivers, friends and ... neuro-oncology, pathology and caregiving, for a day,of information, support, ... detection, at the 7th Annual Brain Tumor Awareness Day,Conference. ... Where: Schwartz Lecture Hall "F" ...
... Offer Licenses to Fundamental Fractional Patent Families, ... Nov. 11 ,Reliant Technologies, Inc. and Palomar ... formation of a Fractional Technology Open Patent,Program ... field to key,intellectual property in the fractional ...
... 11 Covance Inc. (NYSE:,CVD) today announced that it ... Thursday, November 13, 2008 at 1:30 pm (ET).,Investors may ... . In order to register and download any necessary,software, ... headquarters in Princeton, New Jersey, is one of the,world,s ...
... is now the number one online health destination site within the ... audience figures. The new numbers make the health property one of ... visitors. , ... BROOKLYN, N.Y. (Business Wire EON) ...
... NEW ROCHELLE, N.Y., Nov. 11 The American,electorate has ... American can do anything. We hope that the messages ... that any American can do anything.,That includes women. Lawrence ... The cabinet position is about economics. The,contributions of science ...
Cached Medicine News:Health News:Most Single Adults Not Using Condoms 2Health News:Most Single Adults Not Using Condoms 3Health News:Brain Tumor Awareness Day: Free Brain Scans to Promote Early Detection 2Health News:Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program 2Health News:Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program 3Health News:Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program 4Health News: Waterfront Media Announces Everyday Health Network is Number One Online Health Destination : First time in ten years comScore Media Metrix names a new leader in online health 2Health News:Statement From the Rosalind Franklin Society: Lawrence Summers Not the Right Choice for Cabinet Position in Obama Administration 2
... Our Pacemaker Follow-Up Solution makes ... part of our Cardiac Monitoring Center, ... a day, seven days a week ... call any time they experience a ...
... its introduction, the PROTG® GPS™ ... System has delivered on a ... and confidence. PROTG GPS Stents ... new level by adding tantalum ...
Assay development using client's antibodies and antigens to meet diagnostic target...
Gold Labeling kit for antibodies, the Coat-Block-Run Conjugation Kit pH 8-11; contains 1 bottle each of 20 nm and 40 nm Naked Gold...
Medicine Products: